Advances in Cancer Prevention
Open Access

Cervical cancer prevention; HPV vaccination; Targeting human papillomavirus

Introduction

Cervical cancer is a significant global health issue, with approximately 600,000 new cases diagnosed each year, making it the fourth most common cancer among women worldwide. While advancements in treatment have improved outcomes for many patients, prevention remains the most effective strategy for reducing the burden of this disease. In this article, we will explore the importance of cervical cancer prevention and discuss various preventive measures that can help combat this preventable cancer [1].

Role of prevention

Prevention plays a crucial role in the fight against cervical cancer. Unlike many other cancers, cervical cancer is caused by human papillomavirus (HPV), a common sexually transmitted infection [2]. Therefore, primary prevention efforts that target HPV infection are key to reducing the incidence of cervical cancer. Additionally, secondary prevention through regular screening can detect precancerous changes in the cervix early, allowing for timely intervention and treatment to prevent the development of invasive cancer [3].

Hpv vaccination

One of the most effective primary prevention strategies for cervical cancer is HPV vaccination. Vaccines such as Gardasil and Cervarix target the most common cancer-causing strains of HPV, offering protection against infection. Vaccination is recommended for both boys and girls before they become sexually active, ideally between the ages of 9 and 12, to provide maximum benefit. By vaccinating against HPV, we can significantly reduce the risk of cervical cancer and other HPV-related cancers [4].

Regular screening

In addition to vaccination, regular cervical cancer screening is essential for early detection and treatment of precancerous changes in the cervix. Pap smears, also known as Pap tests, and HPV tests are the primary screening methods used to detect abnormal cells or HPV infections that may lead to cervical cancer. Women are encouraged to undergo routine screening according to national guidelines, typically starting at age 21 or when they become sexually active [5].

Education and awareness

Raising awareness about cervical cancer risk factors, prevention strategies, and the importance of early detection is crucial for empowering women to take control of their health. Educational campaigns, community outreach programs, and public health initiatives can provide women with information about cervical cancer, HPV, and the benefits of vaccination and screening [6]. By promoting knowledge and understanding, these efforts can empower women to make informed decisions about their health and seek preventive care when needed [7]. Raising awareness about cervical cancer risk factors, prevention strategies, and the importance of early detection is essential for empowering women to take control of their health. Educational campaigns, community outreach programs, and public health initiatives can provide women with information about cervical cancer, HPV, and the benefits of vaccination and screening. By promoting HPV vaccination, encouraging regular screening, and raising awareness about cervical cancer, we can reduce the burden of this disease and improve outcomes for women worldwide [8].

Discussion

Cultural factors such as fatalism and familism hold relevance within the Hispanic community and may impact communication behaviors. Fatalism regarding cancer suggests a belief that cancer is unavoidable and inevitably leads to death, often correlating inversely with information-seeking behaviors related to cancer [9]. Familism, on the other hand, emphasizes loyalty, support, and interconnectedness within family members and is associated with family communication, particularly among Hispanic adolescents. In a recent skin cancer precision prevention trial involving Hispanic participants, the intervention provided genetic test results and skin cancer prevention information, drawing from Protection Motivation Theory (PMT). PMT suggests that threat appraisal perceived risk and severity and coping appraisal response and self-efficacy influence health behaviors. Through secondary analyses of trial data, we aimed to identify factors associated with information-sharing and informationseeking behaviors regarding skin cancer prevention [10].Utilizing the Comprehensive Model of Information Seeking (CMIS), which considers salience, severity, cancer worry, beliefs, demographics , and personal experience family history of cancer, familism as antecedent constructs motivating information-seeking, we examined associations between CMIS antecedents and PMT constructs with both sharing and seeking information about skin cancer prevention among participants.

Conclusion

Fighting cervical cancer through prevention requires a multifaceted approach that addresses both primary and secondary prevention strategies. By promoting HPV vaccination, encouraging regular screening, and raising awareness about cervical cancer, we can reduce the burden of this disease and save lives. Together, we can work towards a future where cervical cancer is no longer a significant public health concern, and all women have access to the preventive care they need to stay healthy.

References

1. Hamashima C, Shibuya D, Yamazaki H, Inoue K, Fukao A, et al. (2008) The Japanese guidelines for gastric cancer screening. Jpn J Clin Oncol UK 38:259-267.

IndexedAt, GoogleScholar, CrossRef

2. Sabatino SA, White MC, Thompson TD (2015) Cancer screening test use: United States, 2013. MMWR US 64:464-468.

IndexedAt, GoogleScholar     

3. Brawley OW, Kramer BS (2005) Cancer screening in theory and in practice. J Clin Oncol US 23:293-300.

IndexedAt, GoogleScholar

4. Warner E (2011) Breast-cancer screening.  N Engl J Med US 365: 1025-1032.

IndexedAt, GoogleScholar

5. Walsh JME, Terdiman JP (2003) Colorectal cancer screening: scientific review. JAMA US 289:1288-1296.

IndexedAt, GoogleScholar

6. Secretan BL, Scoccianti C (2015). Breast-cancer screening—viewpoint of the IARC Working Group. N Engl J Med US 372:2353-2358.

IndexedAt, GoogleScholar

7. Schwartz LM, Woloshin S, Fowler FJ, Welch HG (2004) Enthusiasm for Cancer Screening in the United States. JAMA US 291:71-78.

GoogleScholar

8. McKinney SM, Sieniek M, Godbole V, Godwin J (2020). International evaluation of an AI system for breast cancer screening. Nature 577:89-94.

IndexedAt, GoogleScholar

9. Fontana RS, Sanderson DR, Woolner LB, Taylor WF, Miller WE, et al. (1986) Lung cancer screening: the Mayo program. J Occup Med US 28:746-750.

IndexedAt, GoogleScholar, CrossRef

10. Berwick DM (1998) Developing and Testing Changes in Delivery of Care. Ann Intern Med US 128: 651-656.

IndexedAt, GoogleScholar, CrossRef